Citation Tools
PDFResearch ethics
Paper
Defining categories of actionability for secondary findings in next-generation sequencing
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Defining categories of actionability for secondary findings in next-generation sequencing
Other content recommended for you
- Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort
- Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification
- Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases
- Comprehensive genetic sequence and copy number analysis for Charcot-Marie-Tooth disease in a Canadian cohort of 2517 patients
- Detection of copy number variants associated with late-onset conditions in ~16 200 pregnancies: parameters for disclosure and pregnancy outcome
- Clinical utility of NGS diagnosis and disease stratification in a multiethnic primary ciliary dyskinesia cohort
- Prospective analysis of 895 patients on a UK Genomics Review Board
- De novo recurrent germline mutation of theBRCA2 gene in a patient with early onset breast cancer
- Variants of Uncertain Significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling
- Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists